首頁 › 慢性淋巴性白血病 › 哥倫比亞特區 › Washington
Washington, DC 的 慢性淋巴性白血病 臨床試驗
22 項針對 慢性淋巴性白血病 的研究正在 Washington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- American Oncology Partners of Maryland Pa, Bethesda · 距離 7 英里
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
招募中3 期
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 距離 7 英里
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
招募中觀察性研究
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距離 7 英里
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
招募中3 期
- GC2202 Study Site 111, Bethesda · 距離 7 英里
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距離 7 英里
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
招募中3 期
- American Oncology Partners of Maryland Pa, Bethesda · 距離 7 英里
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
招募中3 期
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
招募中觀察性研究
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
招募中觀察性研究歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 距離 7 英里
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Maryland Oncology Hematology, Silver Spring · 距離 7 英里
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
招募中早期第 1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中3 期
- American Oncology Partners of Maryland, PA, Bethesda · 距離 7 英里
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
招募中3 期
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 距離 7 英里
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- National Institute of Health, Bethesda · 距離 7 英里
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
招募中2 期
- American Oncology Partners, PA, Bethesda · 距離 7 英里
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中觀察性研究歡迎健康志工
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
招募中3 期
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 距離 7 英里
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 距離 7 英里
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
其他城市的 慢性淋巴性白血病 試驗
- Boston, MA31 項研究
- Columbus, OH28 項研究
- Durham, NC27 項研究
- Seattle, WA20 項研究
- Rochester, MN18 項研究
- New York City, NY18 項研究
- Houston, TX17 項研究
- Baldwin Park, CA16 項研究
- Milwaukee, WI15 項研究
- Chicago, IL14 項研究
- Cincinnati, OH14 項研究
- Nashville, TN13 項研究
Washington 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌55 項研究
- 乳癌46 項研究
- 轉移性癌症43 項研究
- 肺癌41 項研究
- 前列腺癌38 項研究
- 肥胖症33 項研究
- 大腸直腸癌29 項研究
- 心血管疾病28 項研究
- 膀胱癌26 項研究
- 急性髓系白血病24 項研究
- 卵巢癌23 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。